Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference - WMBB News 13 - The Panhandle's News Leader

Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference

  • What's Going Around

  • Wednesday, May 15 2013 11:45 AM EDT2013-05-15 15:45:20 GMT
    While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week. What is pneumonia? Pneumonia
    While cold and flu season is widely discussed, pneumonia season is quickly gaining the spotlight. One in 20 dies from the lung disease each year, and it's what's going around this week.

  • Wednesday, May 8 2013 9:06 AM EDT2013-05-08 13:06:30 GMT
    We all have our aches in our bellies and backs from time to time, but these pains can also be signs of gallstones. Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones are
    Dr. Hatem Mourad from Coastal Urgent Care and Family Medicine warns that gallstones are what's going around.

  • Medical Central is the source for local doctors to advertise their businesses, as well as provide clients and viewers with valuable information on their fields of study.
    •   

Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.

SOURCE Neurocrine Biosciences, Inc.

Live Audio Webcast Wednesday, March 6, 2013

SAN DIEGO, Feb. 27, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Tim Coughlin, Chief Financial Officer of Neurocrine Biosciences, will be presenting at the Cowen and Company 33rd Annual Health Care Conference in Boston.  

The live presentation takes place on Wednesday, March 6 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600 or ir@neurocrine.com.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, tardive dyskinesia, uterine fibroids, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

©2012 PR Newswire. All Rights Reserved.